» Articles » PMID: 39587841

Measuring Metabolic Changes in Cancer Cells Using Two-Photon Fluorescence Lifetime Imaging Microscopy and Machine-Learning Analysis

Overview
Journal J Biophotonics
Date 2024 Nov 26
PMID 39587841
Authors
Affiliations
Soon will be listed here.
Abstract

Two-photon (2P) fluorescence lifetime imaging microscopy (FLIM) was used to track cellular metabolism with drug treatment of auto-fluorescent coenzymes NAD(P)H and FAD in living cancer cells. Simultaneous excitation at 800 nm of both coenzymes was compared with traditional sequential 740/890 nm plus another alternative of 740/800 nm, before and after adding doxorubicin in an imaging time course. Changes of redox states at single cell resolution were compared by three analysis methods: our recently introduced fluorescence lifetime redox ratio (FLIRR: NAD(P)H-a %/FAD-a %), machine-learning (ML) algorithms using principal component (PCA) and non-linear multi-Feature autoencoder (AE) analysis. While all three led to similar biological conclusions (early drug response), the ML models provided statistically the most robust significant results. The advantage of the single 800 nm excitation of both coenzymes for metabolic imaging in above mentioned analysis is demonstrated.

References
1.
Berezin M, Achilefu S . Fluorescence lifetime measurements and biological imaging. Chem Rev. 2010; 110(5):2641-84. PMC: 2924670. DOI: 10.1021/cr900343z. View

2.
Yu J, Guo H, Wang C, Wei Y, Wang H . Increase of reduced nicotinamide adenine dinucleotide fluorescence lifetime precedes mitochondrial dysfunction in staurosporine-induced apoptosis of HeLa cells. J Biomed Opt. 2011; 16(3):036008. DOI: 10.1117/1.3560513. View

3.
Cao R, Wallrabe H, Siller K, Periasamy A . Optimization of FLIM imaging, fitting and analysis for auto-fluorescent NAD(P)H and FAD in cells and tissues. Methods Appl Fluoresc. 2020; 8(2):024001. DOI: 10.1088/2050-6120/ab6f25. View

4.
Wallrabe H, Svindrych Z, Alam S, Siller K, Wang T, Kashatus D . Segmented cell analyses to measure redox states of autofluorescent NAD(P)H, FAD & Trp in cancer cells by FLIM. Sci Rep. 2018; 8(1):79. PMC: 5758727. DOI: 10.1038/s41598-017-18634-x. View

5.
Walsh A, Cook R, Manning H, Hicks D, Lafontant A, Arteaga C . Optical metabolic imaging identifies glycolytic levels, subtypes, and early-treatment response in breast cancer. Cancer Res. 2013; 73(20):6164-74. PMC: 3801432. DOI: 10.1158/0008-5472.CAN-13-0527. View